418 results on '"Huisinga, Wilhelm"'
Search Results
2. A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapy
3. Index analysis: an approach to understand signal transduction with application to the EGFR signalling pathway
4. Three-component contour dynamics model to simulate and analyze amoeboid cell motility
5. Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data
6. Calcium kinetic rates in Caucasian males and females from birth to adulthood
7. A continued learning approach for model-informed precision dosing: updating models in clinical practice
8. Nonparametric goodness-of-fit testing for parametric covariate models in pharmacometric analyses
9. Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncology
10. Analysis of protrusion dynamics in amoeboid cell motility by means of regularized contour flows
11. Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion
12. Bayesian data assimilation to support informed decision-making in individualised chemotherapy
13. Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
14. Leveraging QSP Models for MIPD: A Case Study for Warfarin/INR.
15. Novel mathematical approach to accurately quantify 3D endothelial cell morphology and vessel geometry based on fluorescently marked endothelial cell contours: Application to the dorsal aorta of wild-type and Endoglin-deficient zebrafish embryos.
16. Novel mathematical morphology model identifies dorsal-ventral asymmetry of endothelial cell morphology in dorsal aorta of wild-type and Endoglin-deficient zebrafish embryos
17. Index analysis: An approach to understand signal transduction with application to the EGFR signalling pathway
18. Physiology-based toxicokinetic modelling of aluminium in rat and man
19. Therapeutic drug monitoring of oral targeted antineoplastic drugs
20. Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Response Exemplified by Levofloxacin
21. Three-component contour dynamics model to simulate and analyze amoeboid cell motility in two dimensions
22. C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework
23. Sample‐based robust model reduction for non‐linear systems biology models.
24. A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non‐small cell lung cancer patients.
25. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults
26. Understanding and reducing complex systems pharmacology models based on a novel input–response index
27. Model-Informed Target Morning 17α-Hydroxyprogesterone Concentrations in Dried Blood Spots for Pediatric Congenital Adrenal Hyperplasia Patients
28. Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
29. Cell‐level systems biology model to study inflammatory bowel diseases and their treatment options
30. Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs
31. Absence of Relationship Between Crohnʼs Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohnʼs Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure
32. Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach
33. Impact of altered endogenous IgG on unspecific mAb clearance
34. Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn’s Disease Is Determined by Their Concentration
35. Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
36. Spontaneous transitions between amoeboid and keratocyte-like modes of migration
37. Metastability and Dominant Eigenvalues of Transfer Operators
38. Software Supported Modelling in Pharmacokinetics
39. Adaptive Approach for Modelling Variability in Pharmacokinetics
40. Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools
41. Spontaneous transitions between amoeboid and keratocyte-like modes of migration
42. Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis
43. Evaluation of a Meropenem and Piperacillin Monitoring Program in Intensive Care Unit Patients Calls for the Regular Assessment of Empirical Targets and Easy-to-Use Dosing Decision Tools
44. Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
45. Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients
46. Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models:Results from a Comprehensive Review
47. Error-controlled global sensitivity analysis of ordinary differential equations
48. Gestational influences on the pharmacokinetics of gestagenic drugs: A combined in silico, in vitro and in vivo analysis
49. A continued learning approach for model‐informed precision dosing: Updating models in clinical practice
50. Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.